Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress
Cold Spring Harbor Perspectives in Medicine · 2024
DOI: 10.1101/cshperspect.a041656 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, 2024. Verfasst von Rosane Charlab und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of Clinical Pharmacology, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA Rosane.Charl…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of Clinical Pharmacology, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA Rosane.CharlabOrbach@fda.hhs.gov.
- Office of Clinical Pharmacology, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland 20993, USA.
- Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, USA.
Zitieren
APA
Charlab, R., Leong, R., Shord, S. S., & Reaman, G. H. (2024). Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a041656
Vancouver
Charlab R, Leong R, Shord SS, Reaman GH. Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress. Cold Spring Harbor Perspectives in Medicine. 2024. doi:10.1101/cshperspect.a041656
BibTeX
@article{Charlab2024,
author = {Charlab, Rosane and Leong, Ruby and Shord, Stacy S and Reaman, Gregory H},
title = {Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress},
journal = {Cold Spring Harbor Perspectives in Medicine},
year = {2024},
doi = {10.1101/cshperspect.a041656}
}
EUVIMED